Lifecore Biomedical's market cap is currently ―. The company's EPS TTM is $-0.584; its P/E ratio is ―; Lifecore Biomedical is scheduled to report earnings on April 2, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Nov 24	Aug 24	May 24	Feb 24	Nov 23
Income Statement	-
Total Revenue	$ 32.56M	$ 24.70M	$ 37.88M	$ 35.70M	$ 30.15M
Gross Profit	$ 11.08M	$ 5.39M	$ 17.27M	$ 11.89M	$ 9.96M
EBIT	$ -6.53M	$ -16.25M	$ -19.07M	$ 19.29M	$ 18.25M
EBITDA	$ -4.48M	$ -14.26M	$ -16.82M	$ 21.52M	$ 20.46M
Net Income Common Stockholders	$ -8.70M	$ -15.42M	$ -7.08M	$ 15.63M	$ 14.22M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.46M	$ 5.52M	$ 8.46M	$ 3.07M	$ 3.22M
Total Assets	$ 255.39M	$ 246.82M	$ 253.96M	$ 246.24M	$ 245.82M
Total Debt	$ 119.80M	$ 127.92M	$ 121.28M	$ 117.02M	$ 109.74M
Net Debt	$ 110.35M	$ 122.40M	$ 112.82M	$ 113.95M	$ 106.52M
Total Liabilities	$ 195.63M	$ 207.32M	$ 200.06M	$ 186.81M	$ 203.47M
Stockholders Equity	$ 15.45M	$ -3.94M	$ 11.31M	$ 17.69M	$ 1.42M
Cash Flow	-
Free Cash Flow	$ -8.58M	$ -4.04M	$ 8.64M	$ -7.79M	$ -2.97M
Operating Cash Flow	$ -6.11M	$ -643.00K	$ 8.64M	$ -1.53M	$ 1.01M
Investing Cash Flow	$ -2.47M	$ -3.39M	$ -2.64M	$ -6.25M	$ -3.98M
Financing Cash Flow	$ 12.52M	$ 1.09M	$ -614.00K	$ 7.64M	$ -2.45M

Currency in USD

Lifecore Biomedical Earnings and Revenue History

Income Statement >

Lifecore Biomedical Debt to Assets

Balance Sheet >

Lifecore Biomedical Cash Flow

Cash Flow >

Lifecore Biomedical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing